KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Asset Utilization Ratio: 2019-2024

Historic Asset Utilization Ratio for Esperion Therapeutics (ESPR) over the last 6 years, with Dec 2024 value amounting to 1.21.

  • Esperion Therapeutics' Asset Utilization Ratio fell 3.63% to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year decrease of 3.63%. This contributed to the annual value of 1.21 for FY2024, which is 135.82% up from last year.
  • According to the latest figures from FY2024, Esperion Therapeutics' Asset Utilization Ratio is 1.21, which was up 135.82% from 0.51 recorded in FY2023.
  • In the past 5 years, Esperion Therapeutics' Asset Utilization Ratio registered a high of 1.21 during FY2024, and its lowest value of 0.21 during FY2021.
  • Over the past 3 years, Esperion Therapeutics' median Asset Utilization Ratio value was 0.51 (recorded in 2023), while the average stood at 0.65.
  • In the last 5 years, Esperion Therapeutics' Asset Utilization Ratio slumped by 73.37% in 2021 and then spiked by 135.82% in 2024.
  • Over the past 5 years, Esperion Therapeutics' Asset Utilization Ratio (Yearly) stood at 0.80 in 2020, then plummeted by 73.37% to 0.21 in 2021, then grew by 12.31% to 0.24 in 2022, then surged by 113.85% to 0.51 in 2023, then spiked by 135.82% to 1.21 in 2024.